Gambro Settles Medicare Billing Suit, Signs Corporate Integrity Agreement
This article was originally published in The Gray Sheet
Executive Summary
Gambro Healthcare US will record a second quarter charge of $355 mil. to cover a definitive settlement agreement with the U.S. Department of Justice, expected to be completed by December
You may also be interested in...
NQC, Nephros Pursuing Artificial Kidney Through Separate R&D Efforts
National Quality Care will file an investigational device exemption within the next few months for a wearable artificial kidney device, the firm says
Gambro settlement
Dialysis firm will pay $355 mil. to settle charges related to renal care Medicare billing practices, upon entering into a five-year corporate integrity agreement. The deal finalizes a July preliminary understanding with the Department of Justice (1"The Gray Sheet" July 26, 2004, p. 13). Funds for the settlement were set aside in Q2...
NQC, Nephros Pursuing Artificial Kidney Through Separate R&D Efforts
National Quality Care will file an investigational device exemption within the next few months for a wearable artificial kidney device, the firm says